Genetic Hearing Loss and Gene Therapy

Area of Science:

• Genetics
• Otolaryngology
• Genomics

Background:

• Genetic hearing loss encompasses diverse types, including conductive, sensory, neural, syndromic, and nonsyndromic forms.
• Genes are implicated in nearly half of all hearing loss cases, yet effective treatments remain limited.
• Genetic hearing loss exhibits extreme genetic heterogeneity.

Purpose of the Study:

• To review recent advancements in understanding the genomics of genetic hearing loss.
• To discuss emerging gene therapy technologies for treating hearing impairment.

Main Methods:

• Genomic analysis to identify causative variants and genes associated with hearing loss.
• Review of current gene therapy strategies and challenges in auditory system applications.

Main Results:

• Over 6,000 causative variants have been identified in more than 150 genes linked to hearing loss.
• Gene identification provides insights into auditory system development and function.
• Defective genes represent potential therapeutic targets for future treatments.

Conclusions:

• Significant progress has been made in elucidating the genetic basis of hearing loss.
• The complexity of the auditory system presents challenges for gene therapy development.
• Gene therapy holds promise as a future treatment option for genetic hearing loss.